SS Innovations International, Inc. (SSII): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion Promotes Dr. Vishwa Srivastava to President and Appoints Gary Lo as Chief Financial Officer FORT LAUDERDALE, Fla. – November 13, 2026 – SS Innovations International, Inc. (the “Compa

Event · Exec change
Person
Vishwa Srivastava
Title
President
Action
promoted
Predecessor
Chief Executive Officer – Asia Pacific

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Nov 13, 2026, 1:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 1:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SSII
Neutral
high confidence
Mentioned
$SSII
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SSIINeutralLow
01

Why it matters

The executive changes are routine corporate governance updates with minimal immediate price effect.

02

Market read

Primary disclosure of executive appointments; low trading relevance.

03

What to watch

Potential impact of FDA 510(k) review progress and CE marking timeline on future revenue.

Relevance 6/10Novelty 4/10Timing: immediate filing today

Background

SS Innovations International develops affordable surgical robotic systems and is expanding globally. The 8‑K filing announces senior management changes.

Company-level read

Ticker impact

$SSIINeutralHigh confidence
Context

SEC Form 8‑K reports promotion of Dr. Vishwa Srivastava to President and appointment of Gary Lo as CFO, a new executive change for SS Innovations.

Expected impact

likely neutral as investors assess leadership transition

Evidence & confidence

The filing provides no financial numbers or strategic deals; market impact is typically limited for mid‑cap exec changes.

Market effects

None significant; the robotic surgery sector sees no new product or regulatory event.

Limited to US investors tracking Nasdaq micro‑caps.

Low; no broader market or macro implications.

Counterpoint

If the new leadership accelerates global expansion, the stock could outperform peers.

Key entities

  • SS Innovations International, Inc.

    NASDAQ‑listed developer of surgical robotic technologies.

  • Dr. Vishwa Srivastava

    Promoted to President.

  • Gary Lo

    Appointed Chief Financial Officer.

Related articles

$SSIIMed

SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra

SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Other Events. Exhibit 99.1 SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra FORT LAUDERDALE, Fla. – October 13, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII) , a

$SSIIMed

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SS Innovations Reports Second Quarter 2026 Financial Results Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales FORT LAUDERDALE, FLA – August 13, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: